Cushman & Wakefield Ltd. filings document the regulatory record of a Bermuda-based commercial real estate services company listed under CWK. Its 8-K reports cover quarterly and annual financial results, Regulation FD presentations, changes in financial presentation, and capital-structure actions involving senior secured notes issued through a wholly owned subsidiary.
The company’s proxy materials disclose board matters, executive compensation, shareholder voting items, and governance practices. Other filings record corporate-status matters involving the former Cushman & Wakefield plc and related subsidiary reporting obligations, while the current registrant continues to report as Cushman & Wakefield Ltd.
Cushman & Wakefield Ltd. director Michelle Felman reported bona fide gifts of a total of 34,026 Common Shares on June 1, 2026. The transactions reflect gift transfers rather than any open-market buying or selling.
One 17,013-share gift involved shares previously held directly, leaving her with no direct holdings. Another 17,013-share gift involved shares associated with family trusts. Following these transactions, she reports 44,857 Common Shares held indirectly through family trusts, over which she has investment control, for the sole benefit of certain immediate family members.
Cushman & Wakefield Ltd. director Michelle Felman reported equity compensation activity involving restricted stock units (RSUs). On May 15, 2026, she exercised previously awarded RSUs, converting 17,013 RSUs into the same number of common shares without paying any cash consideration.
On May 14, 2026, she received a new grant of 14,041 RSUs that will vest and settle on May 14, 2027, subject to continued board service. Following these transactions, she holds 17,013 common shares directly, 27,844 common shares indirectly through family trusts over which she has investment control, and 14,041 RSUs outstanding.
Cushman & Wakefield Ltd. director Billie Ida Williamson reported routine equity compensation movements involving restricted stock units (RSUs) and common shares. On May 15, 2026, previously awarded RSUs converted into 17,013 common shares without any cash payment, under the company’s omnibus non-employee director incentive plan.
Following this conversion, Williamson held 106,005 common shares directly. A day earlier, on May 14, 2026, Williamson received a new grant of 14,041 RSUs that will vest and settle into an equal number of common shares on May 14, 2027, if board service continues through that date. The Form 4 shows no open-market purchases or sales, only compensation-related grants and RSU conversions.
PLAVIN STEPHEN D reported acquisition or exercise transactions in this Form 4 filing.
Cushman & Wakefield Ltd. director Stephen D. Plavin reported a compensation-related grant of 21,841 restricted stock units on May 14, 2026. Each RSU represents one common share and requires no purchase price.
The RSUs vest and settle on May 14, 2027, generally contingent on his continued board service through that date. Following this award, he holds 21,841 RSUs directly, each convertible into an equal number of common shares.
Cushman & Wakefield Ltd. reported that director Susan Daimler received a grant of 14,041 restricted stock units (RSUs). These RSUs were granted on May 14, 2026 under the company’s 2026 Omnibus Share and Cash Incentive Plan as equity-based board compensation.
The RSUs convert into an equal number of common shares without any cash payment, but they vest and settle on May 14, 2027, generally requiring her continued board service through that date. After this grant, she is reported as holding 14,041 RSUs directly, with no open-market purchases or sales disclosed in this filing.
Cushman & Wakefield Ltd. reported that director Timothy H. Wennes received a grant of 14,041 restricted stock units (RSUs). These RSUs were awarded under the Cushman & Wakefield Ltd. 2026 Omnibus Share and Cash Incentive Plan and will convert into an equal number of common shares without any cash payment.
The RSUs were granted on May 14, 2026 and are scheduled to vest and settle on May 14, 2027, generally conditional on his continued board service through that date. Following this grant, Wennes holds 14,041 RSUs directly.
Cushman & Wakefield Ltd. director Jodie W. McLean reported compensation-related equity activity. On May 15, 2026, previously awarded restricted stock units (RSUs) for 17,013 shares converted into the same number of common shares without any cash payment, leaving her with 88,836 common shares held directly.
Separately, on May 14, 2026, she received a new grant of 14,041 RSUs that will vest and settle into an equal number of common shares on May 14, 2027, subject to her continued board service. These are routine director equity awards and RSU settlements, not open-market share purchases or sales.
Cushman & Wakefield Ltd. director Angela Sun reported routine equity compensation activity. On May 15, 2026, previously awarded restricted stock units converted into 17,013 common shares without any cash payment, under the company’s non-employee director incentive plan. The same day, the corresponding 17,013 RSUs were fully settled and reduced to zero. On May 14, 2026, she also received a new grant of 14,041 RSUs that will vest and settle on May 14, 2027, subject to her continued board service. Following these transactions, she directly owns 63,511 common shares.
Cushman & Wakefield Ltd. director Rajesh Vennam reported equity compensation activity involving restricted stock units (RSUs). On May 15, he converted 17,013 RSUs into the same number of common shares at no cost under the company’s director incentive plan, bringing his direct common share holdings to 35,516 shares.
On May 14, Vennam also received a new award of 14,041 RSUs that will vest and settle into an equal number of common shares on May 14, 2027, if he continues board service. These are compensation-related grants and conversions rather than open-market buying or selling.
Cushman & Wakefield Ltd. director Jennifer J. McPeek reported routine equity compensation activity. On May 15, 2026, previously awarded restricted stock units (RSUs) covering 17,013 common shares converted into the same number of common shares without any cash changing hands, under the company’s non‑employee director incentive plan.
Separately, on May 14, 2026, she received a new grant of 14,041 RSUs, which are scheduled to vest and settle on May 14, 2027, generally conditioned on her continued board service. Following these transactions, she directly holds 35,516 common shares.